| |
| |
| |
| |
| | | |
|
PR:Q1W4C9 | serine protease inhibitor Kazal-type 13 (human) | | | | | |
| | | | |
|
PR:Q1W4C9-1 | serine protease inhibitor Kazal-type 13 isoform h1 (human) | | | | | |
| | | | |
|
PR:Q1W4C9-2 | serine protease inhibitor Kazal-type 13 isoform h2 (human) | | | | | |
| | | |
|
PR:Q3UTS8 | serine protease inhibitor Kazal-type 13 (mouse) | | | | | |
| | | | |
|
PR:Q3UTS8-1 | serine protease inhibitor Kazal-type 13 isoform 1 (mouse) | | | | | |
| | | |
|
PR:D3ZVP0 | serine protease inhibitor Kazal-type 13 (rat) | | | | | |
| | | | |
|
PR:D3ZVP0-1 | serine protease inhibitor Kazal-type 13 isoform 1 (rat) | | | | | |
| | | |
|
PR:000040846 | serine protease inhibitor Kazal-type 13 isoform 1 | | | | | |
| | | | |
|
PR:Q3UTS8-1 | serine protease inhibitor Kazal-type 13 isoform 1 (mouse) | | | | | |
| | | | |
|
PR:D3ZVP0-1 | serine protease inhibitor Kazal-type 13 isoform 1 (rat) | | | | | |